Ocular Discovery actively welcomes new opportunities to explore strategic partnerships with like-minded companies, researchers, and investors.
Investigators and institutions interested in conducting investigator-initiated pre-clinical and clinical trials with our formulations.
Early asset licensing at individual country or regional level.
Co-development agreements with pharma/biotech companies interested in ocular surface disorders.
Private and institutional investors interested in investing in our promising technologies.
To inquire about partnering/investment opportunities with Ocular Discovery, please send an email to our business development team: email@example.com